Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 2
2017 1
2018 1
2019 3
2020 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP. Rogers CL, et al. Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):790-799. doi: 10.1016/j.ijrobp.2019.11.028. Epub 2019 Nov 29. Int J Radiat Oncol Biol Phys. 2020. PMID: 31786276 Free PMC article. Clinical Trial.
BACKGROUND: Phase 2 cooperative group meningioma trial assessing the safety and efficacy of risk-adaptive management strategies. ...METHODS AND MATERIALS: High-risk patients were those with a new or recurrent World Health Organization (WHO) grade III menin …
BACKGROUND: Phase 2 cooperative group meningioma trial assessing the safety and efficacy of risk-adaptive management strategies. ...M …
Radiation-Induced Meningiomas: An Exhaustive Review of the Literature.
Yamanaka R, Hayano A, Kanayama T. Yamanaka R, et al. World Neurosurg. 2017 Jan;97:635-644.e8. doi: 10.1016/j.wneu.2016.09.094. Epub 2016 Oct 3. World Neurosurg. 2017. PMID: 27713063 Review.
The latency period between radiotherapy for primary lesions and the onset of meningiomas was 22.9 11.4 years. The latency period was shorter for patients with grade III meningioma and for those in the high-dose and intermediate-dose radiation groups who recei …
The latency period between radiotherapy for primary lesions and the onset of meningiomas was 22.9 11.4 years. The latency period was shorter …
Review of controversies in management of non-benign meningioma.
Paldor I, Awad M, Sufaro YZ, Kaye AH, Shoshan Y. Paldor I, et al. J Clin Neurosci. 2016 Sep;31:37-46. doi: 10.1016/j.jocn.2016.03.014. Epub 2016 Jun 20. J Clin Neurosci. 2016. PMID: 27338209 Review.
We found that GTR improves outcome in WHO Grade II meningioma, and should be attempted whenever considered safe. GTR correlates less closely to outcome in Grade III meningioma compared to subtotal resection (STR). Extreme measures to completely resect Grad …
We found that GTR improves outcome in WHO Grade II meningioma, and should be attempted whenever considered safe. GTR correlates less closely …
World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C, Wilson E, Brandner S, Shieff C, Thorne L. Champeaux C, et al. Br J Neurosurg. 2015;29(5):693-8. doi: 10.3109/02688697.2015.1054350. Epub 2015 Jun 22. Br J Neurosurg. 2015. PMID: 26098606
BACKGROUND: Anaplastic meningiomas are uncommon primary intracranial tumours associated with high level of recurrence and low life expectancy. Through three institutions experience, we analysed the clinical characteristics of patients with malignant meningiomas to determin …
BACKGROUND: Anaplastic meningiomas are uncommon primary intracranial tumours associated with high level of recurrence and low life expectanc …
Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A, Jin MC, Meola A, Wong HN, Chang SD. Wu A, et al. Neurosurg Focus. 2019 Jun 1;46(6):E12. doi: 10.3171/2019.3.FOCUS1967. Neurosurg Focus. 2019. PMID: 31153145
Outcomes of interest included local disease control, overall survival, and toxicity, which were compared with historical data on photon-based therapies.RESULTSEleven retrospective studies including 240 patients with atypical (WHO grade II) and anaplastic (WHO grade III …
Outcomes of interest included local disease control, overall survival, and toxicity, which were compared with historical data on photon-base …
Transformation of Grade II to Grade III Rhabdoid-Papillary Meningioma: Is Stereotactic Radiosurgery the Culprit? A Case Report and Literature Review.
Christodoulides I, Lavrador JP, Bodi I, Laxton R, Gullan R, Bhangoo R, Vergani F, Ashkan K. Christodoulides I, et al. World Neurosurg. 2020 Feb;134:337-342. doi: 10.1016/j.wneu.2019.11.019. Epub 2019 Nov 9. World Neurosurg. 2020. PMID: 31715408 Review.
CONCLUSION: To the best of our knowledge, this is the first report to describe malignant transformation of a grade II to grade III meningioma after SRS to date....
CONCLUSION: To the best of our knowledge, this is the first report to describe malignant transformation of a grade II to grade III …
Malignant Transformation and Spine Metastasis of an Intracranial Grade I Meningioma: In Situ Immunofluorescence Analysis of Cancer Stem Cells Case Report and Literature Review.
Baeesa SS, Hussein D, Altalhy A, Bakhaidar MG, Alghamdi FA, Bangash M, Abuzenadah A. Baeesa SS, et al. World Neurosurg. 2018 Dec;120:274-289. doi: 10.1016/j.wneu.2018.09.004. Epub 2018 Sep 8. World Neurosurg. 2018. PMID: 30205223 Review.
The patient had multiple local recurrences of the tumor that showed an aggressive change in behavior and transformation to grade III meningioma, and developed extracranial metastasis to the cervical spine. ...We performed a comprehensive literature review of …
The patient had multiple local recurrences of the tumor that showed an aggressive change in behavior and transformation to grade I …
Correlation Based on the WHO Grading with Tumor Control and Clinical Outcome Following Gamma Knife Radiosurgery in Meningiomas.
Naik V, Pahwa B, Singh M, Kale S, Agrawal D. Naik V, et al. Neurol India. 2023 Mar-Apr;71(Supplement):S140-S145. doi: 10.4103/0028-3886.373628. Neurol India. 2023. PMID: 37026345 Free article.
BACKGROUND AND AIM: The aim of this study was to study the effect of Gamma Knife (GK) on meningiomas based on the World Health Organization's (WHO) grading system in terms of tumor control and final clinical outcome. METHODOLOGY: This retrospective study included clinicora …
BACKGROUND AND AIM: The aim of this study was to study the effect of Gamma Knife (GK) on meningiomas based on the World Health Organization' …
Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma.
Kato Y, Nishihara H, Mohri H, Kanno H, Kobayashi H, Kimura T, Tanino M, Terasaka S, Tanaka S. Kato Y, et al. Brain Tumor Pathol. 2014 Jan;31(1):23-30. doi: 10.1007/s10014-012-0127-8. Epub 2012 Dec 19. Brain Tumor Pathol. 2014. PMID: 23250387 Free article.
We performed immunostaining for COX-2 in 76 cases of meningioma consisting of 44 cases of low-grade (WHO Grade I) and 32 cases of high-grade (29 cases of Grade II and 3 cases of Grade III) meningioma, and evaluated COX-2 expression levels on the basis of stai …
We performed immunostaining for COX-2 in 76 cases of meningioma consisting of 44 cases of low-grade (WHO Grade I) and 32 cases of high-grade …
A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
Bhattacharjee M, Bose I, Sarkar P, Banerjee C, Dutta S, Ghosh A, Mukherjee J, Acharya S, Goswami S, Mazumdar A, Chaudhuri S, Chaudhuri S. Bhattacharjee M, et al. Cancer Invest. 2006 Aug-Sep;24(5):502-13. doi: 10.1080/07357900600814839. Cancer Invest. 2006. PMID: 16939959
METHODS: Functional immune parameters of peripheral blood lymphocytes were assayed by CD2 receptors enumeration through E-rosetting and lymphocyte cytotoxicity assay and assessing the generation of reactive oxygen species by NBT assay of peripheral blood macrophages in patient gr …
METHODS: Functional immune parameters of peripheral blood lymphocytes were assayed by CD2 receptors enumeration through E-rosetting and lymp …
13 results